Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,524.40
(
0.54%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
106.99
(
-2.00%
)
Bitcoin
69,660.51
(
0.94%
)
News Focus
News Focus
Post# of 236489
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Learning53

Send PM Follow Ignore
Followers 32
Posts 1622
Boards Moderated 0
Alias Born 10/06/2015

Learning53

Re: mercurio post# 153601

Friday, 03/19/2021 4:28:56 AM

Friday, March 19, 2021 4:28:56 AM

Post# of 236489
Mercurio, I must admit this IS a viable solution for Janet Woodcock in her handling of Cytodyn's Leronlimab aka Vyrologix. You've identified a path where she can deflect critcism, while appeasing her "future employers, by not allwoing full approval. This clever positioning will allow her to stay on course for a cushy position with Big pharma, when she leaves the FDA.

Slick
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CYDY News
More CYDY News